Pulmocide Limited: Pulmocide Raises $30 Million in Series B Financing Pulmocide Raises $30 Million in Series B Financing Funding to progress novel wholly-owned compounds for RSV and pulmonary Aspergillosis London, UK, 20 March 2017: Pulmocide Ltd, the UK-based...